16 Nov 2025
Align for the future with next gen Myval transcatheter heart valve series
Sponsored by Meril Life Sciences
Anchorperson:
A. Seth
Spokesperson:
O. De Backer
Summary
This session delivers an in-depth update on the next generation Myval transcatheter heart valve (THV) series, covering clinical evidence, optimal implantation strategies, and forthcoming innovations. Attendees will examine operator strategies, interactive CT analyses, live procedural demonstrations, and real-world data, providing a comprehensive perspective on advancing TAVI outcomes.
Learning Objectives
- To be updated about the clinical evidence from Myval THV series
- To learn the best practices for optimal implantation of next gen Myval THV series
- To know about upcoming innovations which should impact patient outcomes for TAVI procedures